Research teams from the University of Sheffield and Rutherford Appleton Laboratory (RAL) in the UK have developed a compound that could kill antibiotic-resistant superbugs.
Schrödinger has raised $110m during a funding round to develop its computational platform, which combines physics-based molecular simulations and machine learning for the exploration of chemical space.
A Zika vaccine candidate co-developed by Emergent BioSolutions and Valneva has turned up positive early-stage results, laying the groundwork for a potential technology transfer to Emergent.